J&J | JNJ - Stock


J&J reported $14.58B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Abbott USD 6.99B 501M Mar/2026
Amgen USD 6.19B 39M Mar/2026
AstraZeneca USD 6.57B 13M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
CONMED USD 366.11M 10.56M Mar/2026
Cooper Companies USD 876.4M 30.4M Dec/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Globus Medical USD 772.6M 13.32M Mar/2026
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
J&J USD 14.58B 392M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Merck USD 6.48B 179M Mar/2026
Merit Medical Systems USD 352.39M 18.68M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Vertex Pharmaceuticals USD 1.77B 79.9M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026
Zoetis USD 2.55B 120M Mar/2026